Most Active InvestorsFind investorsPricing
Start for free
Start for free
Global Health Investment Fund (GHIF) logo

Global Health Investment Fund (GHIF)

North America, New York, United States, New York

Description

Impact investment fund established to finance late-stage development of new drugs, vaccines and diagnostics for public health challenges

Investor Profile

Global Health Investment Fund (GHIF) has backed more than 17 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 35% of its total and boasts 7 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Austria, Australia.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.

Stage Focus

  • Series B (18%)
  • Series Unknown (18%)
  • Series C (18%)
  • Series A (12%)
  • Post Ipo Equity (12%)
  • Series D (6%)
  • Seed (6%)
  • Debt Financing (6%)
  • Post Ipo Debt (6%)

Country Focus

  • United States (53%)
  • Austria (12%)
  • Australia (12%)
  • India (6%)
  • United Kingdom (6%)
  • South Korea (6%)
  • Belgium (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Medical
  • Manufacturing
  • Clinical Trials
  • Life Science
  • Biopharma
  • Health Diagnostics
  • Non Profit
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Global Health Investment Fund (GHIF) frequently co-invest with?

Wellington Partners
Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 2
Farallon Capital Management
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
Omnes Capital
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 2
aws Gründungsfonds
aws Gründungsfonds
Europe, Wien, Austria, Vienna
Co-Investments: 2
Ventech
Ventech
Europe, Ile-de-France, France, Paris
Co-Investments: 2
AXA Investment Managers
AXA Investment Managers
Europe, Ile-de-France, France, Puteaux
Co-Investments: 2
Hadean Ventures
Hadean Ventures
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Korea Investment Partners
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
BC
Boom Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Adjuvant Capital
Adjuvant Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Global Health Investment Fund (GHIF) often collaborate with?

Allan Moss
Allan Moss
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
RD
Rodolphe de Spoelberch
North America, Massachusetts, United States, Boston
Shared Deals: 1
KV
Kimberly Vogel
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Global Health Investment Fund (GHIF)?

Epion Therapeutics

Burlington, Massachusetts, United States

Epion is developing a minimally invasive treatment for an ectatic corneal disease.

BiotechnologyHealth CareLife SciencePersonal HealthPharmaceuticalWellness
Series ASep 30, 2022
Amount Raised: $32,000,000
Monod Bio

Seattle, Washington, United States

Monod Bio is a life sciences company developing biosensors for protein and other analyte detection.

BiotechnologyHealth CareLife ScienceMedical
SeedAug 15, 2022
Amount Raised: $25,000,000
Endpoint Health

Palo Alto, California, United States

Endpoint Health is a precision immunology company

Health Care
Series AJun 2, 2022
Amount Raised: $52,000,000
Eyenuk

Woodland Hills, California, United States

Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.

Artificial Intelligence (AI)DiabetesHealth CareHealth DiagnosticsMedical Device
Series UnknownJul 20, 2021
Amount Raised: $6,200,000
Alydia Health

Menlo Park, California, United States

Alydia Health is a medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage.

BiotechnologyHealth CareMedical Device
Series CJul 30, 2020
Amount Raised: $13,900,000
Themis Bioscience

Vienna, Wien, Austria

Themis Bioscience is a start-up biotechnology company.

BiotechnologyClinical TrialsHealth Care
Series DSep 18, 2019
Amount Raised: $44,117,971
Alydia Health

Menlo Park, California, United States

Alydia Health is a medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage.

BiotechnologyHealth CareMedical Device
Series BAug 28, 2018
Amount Raised: $10,278,518
Univercells

Gosselies, Hainaut, Belgium

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

BiotechnologyHealth CareManufacturing
Series BJul 16, 2018
Amount Raised: $18,734,836
Themis Bioscience

Vienna, Wien, Austria

Themis Bioscience is a start-up biotechnology company.

BiotechnologyClinical TrialsHealth Care
Series CJan 3, 2018
Amount Raised: $12,011,478
Iantech

Reno, Nevada, United States

Iantech is a developer of a cataract treatment device.

BiotechnologyHealth CareInformation TechnologyMedical Device
Series CJul 13, 2017
Amount Raised: $4,500,005
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator